Cargando…
Theragnostic Aspects and Radioimmunotherapy in Pediatric Tumors
The use of theragnostic radiopharmaceuticals in nuclear medicine has grown rapidly over the years to combine the diagnosis and therapy of tumors. In this review, we performed web-based and desktop literature research to investigate and explain the potential role of theragnostic imaging in pediatric...
Autores principales: | Cimini, Andrea, Ricci, Maria, Chiaravalloti, Agostino, Filippi, Luca, Schillaci, Orazio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312954/ https://www.ncbi.nlm.nih.gov/pubmed/32481723 http://dx.doi.org/10.3390/ijms21113849 |
Ejemplares similares
-
Molecular Imaging in Pediatric Brain Tumors
por: Chiaravalloti, Agostino, et al.
Publicado: (2019) -
Positron Emission Tomography (PET) and Neuroimaging in the Personalized Approach to Neurodegenerative Causes of Dementia
por: Ricci, Maria, et al.
Publicado: (2020) -
18F-FDOPA PET/CT SUV-Derived Indices and Volumetric Parameters Correlation in Patients with Primary Brain Tumors
por: Chiaravalloti, Agostino, et al.
Publicado: (2021) -
Tau Biomarkers in Dementia: Positron Emission Tomography Radiopharmaceuticals in Tauopathy Assessment and Future Perspective
por: Ricci, Maria, et al.
Publicado: (2021) -
Peptide Receptor Radionuclide Therapy and Primary Brain Tumors: An Overview
por: Cimini, Andrea, et al.
Publicado: (2021)